Percutaneous closure of atrial septal defect: a consensus document of the joint group of experts from the Association of Cardiovascular Interventions and the Grown-Up Congenital Heart Disease Section of the Polish Cardiac Society

Abstract

communication. There are 5 types of anatomic defects known: • Secundum ASD (ASD II): 80% to even more than 90% of ASDs in the adult population; located in the fossa ovalis region and its surrounding tissue. Background information on atrial septal defect Atrial septal defect (ASD) is one of the most prevalent congenital heart defects and may frequently remain undiagnosed until adulthood. 1-4 It is a consequence of various embryological disorders that cause interatrial

Adult atrial septal defect device closure with floppy rims

“…The deficient posteroinferior rim occurs in 3.3% of patients with secundum ASD [1]. Percutaneous closure of this defect is feasible but even if the device is well implanted and initially stable, it can slip to the IVC, which usually takes place a few hours after the procedure or causes cyanosis because the implant's straddling over the IVC with a right-to-left shunt.…”

“…Specific indications for surgical approach include ASD other than secundum, lack of sufficient rims (<5 mm) other than towards aorta, and the need for other cardiosurgical interventions. The deficient retro-aortic rim is most common and present in 36-57% of patients with secundum ASD but most leading centers treat these patients percutaneously [1,2]. Rim is defined as being floppy if it moves back and forth with blood flow and flutters.…”

The use of Amplatzer devices in the percutaneous treatment of congenital heart defects in children and adults based on own experience

“…We performed 1847 procedures of ASD tran scatheter closure at our Institute in the years 1997-2021 according to the guidance of the Association of Cardiovascular Interventions and the GrownUp Congenital Heart Disease Section of the Polish Cardiac Society [1] (Figure 1). We published our preliminary data on the efficacy of TT of ASD in 2004 [2].…”

Efficacy and safety of the Amplatzer Duct Occluder II for ventricular septal defect closure: a meta-analysis

“…Device thrombosis was understood as a thrombus on the occluder or in the catheter insertion route. 13 However, studies with small sample sizes may not provide sufficient data to influence clinical practice; for example, Kanaan et al 8 showed a success rate of 93%, but Vijayalakshmi et al 11 demonstrated a rate of 100%. Thus, a study with a larger sample size is needed to objectively evaluate the potential value of VSD closure with the ADO II.…”